L'hôpital nord de Marseille est l'un des principaux hôpitaux de la ville. Il est situé dans le quartier de Notre-Dame-Limite, dans le 15ᵉ arrondissement. L'hôpital fait partie de l'Assistance publique - Hôpitaux de Marseille. L'hôpital construit par René Egger est inauguré en 1964.

During the past decade, Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" in a lesser frequency.

Most popular intervention types in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (4 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Cisplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".